Clinical Trial: A Phase III Clinical Study of H077 Sustained-Release Tablets Compared With Silodosin Capsules in the Treatment of Benign Prostatic Hyperplasia

U.S., Aug. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07146386) titled 'A Phase III Clinical Study of H077 Sustained-Release Tablets Compared With Silodosin Capsules in the Treatment of Benign Prostatic Hyperplasia' on Aug. 12.

Brief Summary: This is a randomized, double-blind, controlled, non-inferiority multicenter Phase III clinical study to evaluate the efficacy and safety of H077 sustained-release tablets versus silodosin capsules in treating benign prostatic hyperplasia.

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Benign Prostatic Hyperplasia Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms

Intervention: DRUG: H077 sustained-release tablet

Subjects are a...